Suchergebnisse - "Rheumatoid Arthritis"

PubPharm (227)

1

Anti-rheumatoid arthritis potential of Acorus calamus L. extract by interleukin-17 inhibition: Molecular insights through an in silico study

in: Journal of Pharmacy & Pharmacognosy Research | 2024

von Parawansah | Rizki Rahmadi Pratama | Nuralifah | +4

2

Recent Advances in the Treatment of Ocular Complications of Rheumatoid Arthritis: A review of current literature

in: Journal of Education, Health and Sport | 2024

von Olgerd Duchnevič | Iwona Galasińska | Beniamin Michalik | +4

3

Upper digestive tract bleeding as a clinical presentation of non-Hodgkin's lymphoma

enthalten in: Revista medica del Instituto Mexicano del Seguro Social | 2023

von Medina-Marroquín, R. | González-Godínez, I. | Maldonado-López, C. | +1

4

Biological treatment and exercise as an alternative to typical rheumatoid arthritis therapy: pathophysiology and effects

in: Journal of Education, Health and Sport | 2023

von Artur Aghadi | Kinga Brzuszkiewicz | Edyta Dybała | +5

5

Rheumatoid arthritis – symptoms, diagnosis, treatment

in: Journal of Education, Health and Sport | 2022

von Dominik Machaj | Alicja Płaczek | Katarzyna Cyboran | +2

6

Effect of Rituximab on the circulating levels of cytokines produced or not produced by B lymphocytes in patients with rheumatoid arthritis

in: Iatreia | 2022

von Segura-González, A. | Tovar-Sánchez, C. | Franco-Cortés, M. | +1

7

Pseudochylothorax in a patient with rheumatoid arthritis: an unusual pleural effusion

in: Medicina Clínica Práctica | 2022

von Maialen Palomino Alonso | María del Palacio Tamarit

8

Assessment of the functional status of patients with rheumatoid arthritis as a result of the physical therapy programme

in: Journal of Education, Health and Sport | 2022

von A. Nogas | I. Grygus

9

Changes in functional disorders of the wrist and hand as a marker of the effectiveness of a physical therapy programme for patients with rheumatoid arthritis

in: Journal of Education, Health and Sport | 2022

von A. Nogas | I. Grygus

10

Estudio abierto, multinacional para evaluar la seguridad, tolerabilidad y eficacia de tocilizumab en pacientes con artritis reumatoide activa en tratamiento con FAMEs no biológicos que tienen una respuesta inadecuada al tratamiento actual con FAMEs no biológicos y/o terapia anti-TNF.Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy : Estudio abierto, multinacional para evaluar la seguridad, tolerabilidad y eficacia de tocilizumab en pacientes con artritis reumatoide activa en tratamiento con FAMEs no biológicos que tienen una respuesta inadecuada al tratamiento actual con FAMEs no biológicos y/o terapia anti-TNF.Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy

enthalten in: WHO International Clinical Trials Registry Platform | 2021

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]